Literature DB >> 22083364

Henoch-Schönlein nephritis with nephrotic state in children: predictors of poor outcomes.

Hitoshi Wakaki, Kenji Ishikura.   

Abstract

Entities:  

Mesh:

Year:  2011        PMID: 22083364     DOI: 10.1007/s00467-011-2052-1

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


× No keyword cloud information.
  3 in total

1.  Outcome of children with heavy non-nephrotic proteinuria in Henoch-Schönlein nephritis.

Authors:  Shuichiro Fujinaga; Amane Endo; Daishi Hirano
Journal:  Pediatr Nephrol       Date:  2011-11-11       Impact factor: 3.714

2.  Treatment strategies for Henoch-Schönlein purpura nephritis by histological and clinical severity.

Authors:  Takeshi Ninchoji; Hiroshi Kaito; Kandai Nozu; Yuya Hashimura; Kyoko Kanda; Ichiro Kamioka; Yuko Shima; Kiyoshi Hamahira; Koichi Nakanishi; Ryojiro Tanaka; Norishige Yoshikawa; Kazumoto Iijima; Masafumi Matsuo
Journal:  Pediatr Nephrol       Date:  2011-01-04       Impact factor: 3.714

3.  Henoch-Schönlein purpura nephritis with nephrotic state in children: predictors of poor outcomes.

Authors:  Hitoshi Wakaki; Kenji Ishikura; Hiroshi Hataya; Yuko Hamasaki; Tomoyuki Sakai; Nahoko Yata; Tetsuji Kaneko; Masataka Honda
Journal:  Pediatr Nephrol       Date:  2011-03-04       Impact factor: 3.714

  3 in total
  2 in total

1.  [Analysis of clinical characteristics of Henoch-Schonlein purpura patients from different altitudes in plateau areas].

Authors:  H Wei; Z Luo
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2021-12-18

2.  Epidemiology of biopsy-proven Henoch-Schönlein purpura nephritis in children: A nationwide survey in Japan.

Authors:  Chikako Terano; Riku Hamada; Ichiro Tatsuno; Yuko Hamasaki; Yoshinori Araki; Yoshimitsu Gotoh; Koichi Nakanishi; Hitoshi Nakazato; Takeshi Matsuyama; Kazumoto Iijima; Norishige Yoshikawa; Tetsuji Kaneko; Shuichi Ito; Masataka Honda; Kenji Ishikura
Journal:  PLoS One       Date:  2022-07-08       Impact factor: 3.752

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.